Sun Pharmaceutical Industries today 28th July reported a consolidated net profit of Rs 501 crore for the first quarter ended June 30, 2011.
The firm had posted net profit of Rs 564 crore for the same quarter last fiscal, but said the figures were not comparable due to the acquisition of Israel's Taro Pharmaceutical Industries, which became its subsidiary in September last year.
For the first quarter this fiscal, total income stood at Rs 1,636 crore, compared to Rs 1,365 crore in the corresponding year-ago period, the company said.
src-BS & rediff
Posts
No comments:
Post a Comment